ORYX ALPHA Trademark
ORYX ALPHA is a USPTO trademark filed by ORYX Verwaltungs GmbH. Status: Cancelled.
Trademark Facts
| Mark | ORYX ALPHA |
|---|---|
| Serial Number | 79159154 |
| Registration Number | 4879040 |
| Status | Cancelled |
| Filing Date | 2014-10-27 |
| Registration Date | 2016-01-05 |
| Mark Type | Combined |
| Nice Classes | 005 (Pharmaceuticals), 035 (Advertising & Business), 036 (Financial Services), 042 (Software & IT), 045 (Legal Services) |
| Owner | ORYX Verwaltungs GmbH |
| Attorney of Record | William J. Seiter |
| Prosecution Events | 36 |
| Latest Event | DENA on 2025-05-23 |
Goods & Services
Pharmaceutical and veterinary preparations for the treatment of cancer and autoimmune and neurodegenerative diseases and diseases of the central nervous system; Financial and monetary affairs, namely, financial information, management and analysis services; financial management; investment of funds and mutual funds investment; development of usage concepts for intellectual property with regard to financial matters, namely, advising others regarding intellectual property investments; financial sponsorship of research and development of pharmaceutical and veterinary preparations for the treatment of cancer and autoimmune and neurodegenerative diseases and diseases of the central nervous system; Advertising; marketing services; market research; market analysis; public opinion polling; public relations; business management; business administration; business consultancy and advisory services; business consulting services; personnel consultancy and personnel management consultancy; office functions; organization of trade fairs for commercial or advertising purposes; Consulting services in the field of managing intellectual properties, namely, advising others concerning investments in intellectual property assets and intangible business assets, both directly and indirectly through other entities; Monitoring intellectual property rights for legal advisory purposes; licensing of industrial property rights and copyright; Scientific and technological services, namely, scientific research, analysis and testing in the field of pharmaceutical and veterinary preparations for the treatment of cancer and autoimmune and neurodegenerative diseases and diseases of the central nervous system